NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-068-2018-0-US-01 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 US 62/628,454 Abandoned
NCI E-227-2006-5-AU-12 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS AU DIV 2018200921 Issued
NCI E-041-2018-0-US-01 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER US 62/627,926 Abandoned
NIDA E-023-2018-0-US-01 DREADD ACTUATORS US 62/627,527 Abandoned
NLM E-107-2010-2-US-18 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/890,034 Abandoned
NCI E-034-2020-0-PCT-02 KRAS Peptide Vaccine Compositions And Method Of Use PCT PCT PCT/US2018/016890 Expired
NCI E-034-2020-0-CN-03 KRAS Peptide Vaccine Compositions And Method Of Use CN National Stage 201880023091.7 Pending
NCI E-034-2020-0-EP-04 KRAS Peptide Vaccine Compositions And Method Of Use EP National Stage 18747250.1 Abandoned
NCI E-106-2018-0-US-01 Compounds for Cancer Chemotherapeutic Sensitization US 62/626,520 Abandoned
NICHD E-348-2013-0-EP-11 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME EP DIV 18154812.4 Issued
NCI E-244-2015-0-AU-03 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use AU National Stage 2016302237 Issued
NCI E-249-2015-0-US-11 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS US National Stage 15/749,832 11065313 Issued PDF
NCI E-244-2015-0-IE-19 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use IE EP 16751434.8 Issued
NCI E-244-2015-0-IT-20 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use IT EP 16751434.8 Issued
NCI E-244-2015-0-ES-16 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use ES EP 16751434.8 Issued
NCI E-244-2015-0-EP-06 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use EP National Stage 16751434.8 Issued
NCI E-244-2015-0-CH-14 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use CH EP 16751434.8 Issued
NCI E-244-2015-0-GB-18 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use GB EP 16751434.8 Issued
NCI E-244-2015-0-FR-17 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use FR EP 16751434.8 Issued
NCI E-244-2015-0-DE-15 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use DE EP 16751434.8 Issued
NCI E-244-2015-0-JP-08 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use JP National Stage 2018-505434 Issued
NCI E-215-2017-0-US-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES US 62/624,967 Abandoned
NIDCR E-026-2018-1-US-01 USE OF COPEPTIN TO MODULATE THE IMMUNE RESPONSE AND HEMATOPOIESIS, AND STIMULATE BONE US 62/625,242 Abandoned
NEI E-094-2016-0-AU-04 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY AU National Stage 2018214954 Issued
NCI E-142-2014-0-US-03 ANTIGEN-BINDING PROTEINS TARGETING CD56 AND USES THEREOF US CON 15/884,608 10730941 Issued PDF
NCI E-244-2015-0-US-10 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US National Stage 15/749,214 10550164 Issued PDF
NEI E-094-2016-0-PCT-02 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY PCT PCT PCT/US2018/016101 Expired
NEI E-094-2016-0-EP-06 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY EP National Stage 18704773.3 Pending
NEI E-094-2016-0-JP-07 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY JP National Stage 2019-538157 Abandoned
NEI E-094-2016-0-CA-05 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY CA National Stage 3048523 Pending
NCI E-231-2015-0-SG-08 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer SG National Stage 11201800787W Issued
NICHD E-072-2017-0-PCT-02 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE PCT PCT PCT/US2018/015957 Expired
NICHD E-072-2017-0-EP-05 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE EP National Stage 18707167.5 Abandoned
NICHD E-072-2017-0-JP-06 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE JP National Stage 2019-540667 Issued
NICHD E-072-2017-0-AU-03 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE AU National Stage 2018212002 Abandoned
NICHD E-072-2017-0-CA-04 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE CA National Stage 3050917 Abandoned
NCI E-069-2018-0-US-01 Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation US 62/623,496 Abandoned
NCI E-221-2015-0-US-03 ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS US National Stage 15/747,620 10548987 Issued PDF
NCATS E-046-2018-2-PCT-01 AUTOPHAGY INDUCERS FOR TREATMENT OF CNS CONDITIONS PCT PCT COMB PCT/US2018/015293 Expired
NEI E-044-2018-0-US-01 BMSC DERIVED EXOSOMES AND MIRNA TO TREAT GLAUCOMA US 62/622,032 Abandoned
NCI E-244-2015-0-IL-07 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use IL National Stage 257127 Issued
NCI E-171-2018-7-IL-04 MODIFIED CELLS AND METHODS OF THERAPY IL National Stage 257105 Issued
NICHD E-030-2018-0-US-01 METHODS AND COMPOSITIONS FOR TREATING LYSOSOMAL STORAGE DISEASES US 62/620,811 Abandoned
NINDS E-088-2018-0-TW-04 Anti-HERV-K Envelope Antibody And Uses Thereof TW ORD 107102219 Issued
NEI E-284-2012-2-US-07 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE US CON 15/876,821 1035-03-06 Issued PDF
NCI E-116-2017-2-US-01 Compositions and Methods For Treating Cancer With Anti-CD33 Immunotherapy US 62/620,139 Abandoned
NIAID E-033-2018-0-US-01 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE US 62/620,051 Abandoned
NHLBI E-134-2017-3-JP-11 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 JP National Stage 2019-539809 Issued
NHLBI E-134-2017-3-AU-03 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 AU National Stage 2018210404 Issued
NHLBI E-134-2017-3-PCT-01 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 PCT PCT COMB PCT/US2018/014532 Expired